Logo
x

Search

Subscribe Now

therapies

Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases

Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases

  • October 27, 2021
Progenity Signs an Agreement with Ionis Pharmaceuticals to Evaluate Oral Biotherapeutics Delivery System with Antisense Oligonucleotides

Progenity Signs an Agreement with Ionis Pharmaceuticals to Evaluate Oral Biotherapeutics Delivery System with Antisense Oligonucle...

  • April 7, 2021
Pfizer Collaborates with Dewpoint to Develop Therapies for Rare Form of Muscular Dystrophy

Pfizer Collaborates with Dewpoint to Develop Therapies for Rare Form of Muscular Dystrophy

  • January 7, 2021
Novartis to Acquire Cadent Therapeutics for ~$770M

Novartis to Acquire Cadent Therapeutics for ~$770M

  • December 17, 2020
BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

  • October 29, 2020
Sarepta Therapeutics Collaborates with University of Florida to Accelerate the Development of Therapies for Rare Genetic Diseases

Sarepta Therapeutics Collaborates with University of Florida to Accelerate the Development of Therapies for Rare Genetic Diseases

  • August 12, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.